⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for lurbinectedin

Every month we try and update this database with for lurbinectedin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USANCT04291937
Small Cell Lung...
Lurbinectedin
18 Years - Jazz Pharmaceuticals
Lurbinectedin (PM01183) Combined With Pembrolizumab in Small Cell Lung Cancer.NCT04358237
Small Cell Lung...
Lurbinectedin
Pembrolizumab
18 Years - Blanco, Dr Antonio Calles MD
Clinical Pharmacokinetic Study of Lurbinectedin in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic ImpairmentNCT05101265
Advanced Solid ...
Hepatic Impairm...
Lurbinectedin
Lurbinectedin
18 Years - PharmaMar
Study of Lurbinectedin (PM01183) in Combination With Cisplatin in Patients With Solid TumorsNCT01980667
Advanced Solid ...
lurbinectedin (...
Cisplatin
18 Years - PharmaMar
Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic SyndromeNCT01314599
Acute Leukemia
PM01183 1 mg Po...
18 Years - PharmaMar
A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung CancerNCT05091567
Small-Cell Lung...
Atezolizumab
Lurbinectedin
Carboplatin
Etoposide
18 Years - Hoffmann-La Roche
Study Escalating Doses of PM01183 in Combination With Fixed Doxorubicin in Patients With Specific Advanced Unresectable Solid TumorsNCT01970540
Endometrial Ade...
Neuroendocrine ...
Small-cell Lung...
lurbinectedin (...
Doxorubicin
18 Years - 75 YearsPharmaMar
A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast CancerNCT01525589
Breast Cancer
PM01183
18 Years - 75 YearsPharmaMar
Study to Evaluate the Effect of Bosentan on the Pharmacokinetics of Lurbinectedin in Patients With Advanced Solid TumorsNCT05072106
Advanced Solid ...
Lurbinectedin
Bosentan
18 Years - PharmaMar
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid TumorsNCT02611024
Advanced Solid ...
Glioblastoma
Soft Tissue Sar...
Endometrial Car...
Epithelial Ovar...
Mesothelioma
Gastroenteropan...
SCLC
Gastric Carcino...
Pancreatic Aden...
Colorectal Carc...
Neuroendocrine ...
Lurbinectedin
Irinotecan
18 Years - PharmaMar
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung CancerNCT05740566
Small Cell Lung...
Tarlatamab
Lurbinectedin
Topotecan
Amrubicin
18 Years - Amgen
Lurbinectedin + Doxorubicin In LeiomyosarcomaNCT05099666
Advanced Soft-t...
Metastatic Soft...
Advanced Leiomy...
Leiomyosarcoma ...
Lurbinectedin
Doxorubicin
18 Years - Massachusetts General Hospital
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)NCT05153239
Relapsed Small ...
Irinotecan
Lurbinectedin
Irinotecan
Topotecan
Lurbinectedin
18 Years - PharmaMar
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)NCT05153239
Relapsed Small ...
Irinotecan
Lurbinectedin
Irinotecan
Topotecan
Lurbinectedin
18 Years - PharmaMar
Dose Attenuated Chemotherapy in Compromised Patients With Lung CancerNCT05800587
Lung Cancer
Small-cell Lung...
Non Small Cell ...
Carboplatin
Pemetrexed
Paclitaxel
Nab paclitaxel
Docetaxel
Gemcitabine
Etoposide
Irinotecan
Topotecan
Lurbinectedin
18 Years - Fox Chase Cancer Center
Neoadjuvant Lurbinectedin and Preoperative Radiation for Treating Soft Tissue SarcomasNCT06217536
Locally Advance...
Lurbinectedin
Radiotherapy
Non-investigati...
18 Years - University of California, San Francisco
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic LeiomyosarcomaNCT06088290
Leiomyosarcoma
Lurbinectedin
Doxorubicin
18 Years - PharmaMar
Study of Lurbinectedin (PM01183) in Combination With Cisplatin in Patients With Solid TumorsNCT01980667
Advanced Solid ...
lurbinectedin (...
Cisplatin
18 Years - PharmaMar
A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast CancerNCT01525589
Breast Cancer
PM01183
18 Years - 75 YearsPharmaMar
LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue SarcomaNCT05876715
Advanced Soft-t...
Lurbinectedin
18 Years - 90 YearsSarcoma Oncology Research Center, LLC
Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic SyndromeNCT01314599
Acute Leukemia
PM01183 1 mg Po...
18 Years - PharmaMar
LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue SarcomaNCT05876715
Advanced Soft-t...
Lurbinectedin
18 Years - 90 YearsSarcoma Oncology Research Center, LLC
Lurbinectedin in FET-Fused TumorsNCT05918640
Ewing Sarcoma
Desmoplastic Sm...
Pediatric Cance...
Undifferentiate...
Lurbinectedin
10 Years - Children's Hospital of Philadelphia
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung CancerNCT06203210
Small Cell Lung...
Ifinatamab deru...
Topotecan
Amrubicin
Lurbinectedin
18 Years - Daiichi Sankyo
Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.NCT03213301
Malignant Pleur...
Lurbinectedin
18 Years - Swiss Group for Clinical Cancer Research
Study Escalating Doses of PM01183 in Combination With Fixed Doxorubicin in Patients With Specific Advanced Unresectable Solid TumorsNCT01970540
Endometrial Ade...
Neuroendocrine ...
Small-cell Lung...
lurbinectedin (...
Doxorubicin
18 Years - 75 YearsPharmaMar
Study of Lurbinectedin (PM01183) in Combination With Cisplatin in Patients With Solid TumorsNCT01980667
Advanced Solid ...
lurbinectedin (...
Cisplatin
18 Years - PharmaMar
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing SarcomaNCT05734066
Refractory Ewin...
Relapsed Ewing ...
Ewing Sarcoma
Lurbinectedin
2 Years - 30 YearsJazz Pharmaceuticals
Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian CancerNCT05636111
Ovarian Cancer
Paclitaxel
Bevacizumab
Lurbinectedin
18 Years - M.D. Anderson Cancer Center
Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.NCT03213301
Malignant Pleur...
Lurbinectedin
18 Years - Swiss Group for Clinical Cancer Research
A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung CancerNCT05091567
Small-Cell Lung...
Atezolizumab
Lurbinectedin
Carboplatin
Etoposide
18 Years - Hoffmann-La Roche
Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLCNCT04610658
Small-cell Lung...
Relapsed Small ...
Recurrent Small...
Nivolumab
Ipilimumab
Lurbinectedin
18 Years - H. Lee Moffitt Cancer Center and Research Institute
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic LeiomyosarcomaNCT06088290
Leiomyosarcoma
Lurbinectedin
Doxorubicin
18 Years - PharmaMar
Escalating Doses of PM01183 in Combination With Gemcitabine in Patients With Specific Unresectable Solid TumorsNCT01970553
Specific Advanc...
lurbinectedin (...
Gemcitabine
18 Years - 75 YearsPharmaMar
Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian CancerNCT05636111
Ovarian Cancer
Paclitaxel
Bevacizumab
Lurbinectedin
18 Years - M.D. Anderson Cancer Center
Study of Trilaciclib and LurbinectidinNCT05578326
Lung Cancer
Small-cell Lung...
Trilaciclib
Lurbinectedin
18 Years - UNC Lineberger Comprehensive Cancer Center
Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.NCT03213301
Malignant Pleur...
Lurbinectedin
18 Years - Swiss Group for Clinical Cancer Research
Neoadjuvant Lurbinectedin and Preoperative Radiation for Treating Soft Tissue SarcomasNCT06217536
Locally Advance...
Lurbinectedin
Radiotherapy
Non-investigati...
18 Years - University of California, San Francisco
Lurbinectedin in FET-Fused TumorsNCT05918640
Ewing Sarcoma
Desmoplastic Sm...
Pediatric Cance...
Undifferentiate...
Lurbinectedin
10 Years - Children's Hospital of Philadelphia
Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)NCT06228066
Small Cell Carc...
High Grade Neur...
Lurbinectedin
Avelumab
18 Years - 120 YearsNational Institutes of Health Clinical Center (CC)
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)NCT05153239
Relapsed Small ...
Irinotecan
Lurbinectedin
Irinotecan
Topotecan
Lurbinectedin
18 Years - PharmaMar
Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLCNCT04610658
Small-cell Lung...
Relapsed Small ...
Recurrent Small...
Nivolumab
Ipilimumab
Lurbinectedin
18 Years - H. Lee Moffitt Cancer Center and Research Institute
Study to Evaluate the Effect of Bosentan on the Pharmacokinetics of Lurbinectedin in Patients With Advanced Solid TumorsNCT05072106
Advanced Solid ...
Lurbinectedin
Bosentan
18 Years - PharmaMar
Lurbinectedin in FET-Fused TumorsNCT05918640
Ewing Sarcoma
Desmoplastic Sm...
Pediatric Cance...
Undifferentiate...
Lurbinectedin
10 Years - Children's Hospital of Philadelphia
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: